A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This is a randomized, observer-blinded, placebo-controlled study to evaluate safety, tolerability, immunogenicity, and pharmacokinetics of repeat dosing of intravenous (IV) UTTR1147A. The study will consist of a repeat dose escalation in HVs, in participants with UC, and in participants with CD across multiple sites.
Epistemonikos ID: 29e3e2dd3f047bad17a6df38937ca2d142289a60
First added on: Mar 23, 2022